menu
    • menu

    Company profile for InnoGen Pharmaceuticals, Inc.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InnoGen Pharmaceuticals Inc., is the Company that makes a difference in the pharmaceutical industry: because its thrust is geared towards improving existing products into new forms making them acceptable drugs; that are cost-effective but of excellent quality, that will redound to the benefit and welfare of the end-users. InnoGen Pharmaceuticals Inc., resulted from the fusion of nine Filipino-owned pharmaceutical companies wh...
    InnoGen Pharmaceuticals Inc., is the Company that makes a difference in the pharmaceutical industry: because its thrust is geared towards improving existing products into new forms making them acceptable drugs; that are cost-effective but of excellent quality, that will redound to the benefit and welfare of the end-users. InnoGen Pharmaceuticals Inc., resulted from the fusion of nine Filipino-owned pharmaceutical companies which was initiated in June 2010. From the different therapeutic class of products; into it now only has the following areas of concentration: the Cardio-Metabolic Division, CNS and Gastro Division, and the Anti-infectives and Respiratory Division. Ethical Marketing and Promotions are on a national coverage. InnoGen Pharmaceuticals Inc., is proud to be the first national company that has provided second to innovator pharmaceutical products, most of which are off-patent molecules. InnoGen Pharmaceuticals Inc., has spearheaded and made way for technology transfer and partnership with big pharmaceutical companies around the world, enabling this company to avail itself of the latest information and facilities in the Industry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InnoGen Pharmaceuticals, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    No. 124-126 Scout Dr. Lazcano Street, Brgy. Sacred Heart, Quezon City, 1103 , ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://innogengroup.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innogen to Present Phase 2b ENLIGHT Data at ADA 2026
    Innogen to Present Phase 2b ENLIGHT Data at ADA 2026

    29 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innogen-to-present-phase-iib-enlight-study-results-for-efsubaglutide-alfa-at-the-2026-ada-scientific-sessions-302785669.html

    PR NEWSWIRE
    29 May 2026
    Share Share
    Innogenix`s Generic Baclofen Receives Approval in US
    Innogenix`s Generic Baclofen Receives Approval in US

    14 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212378

    FDA
    14 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search